The xanthine oxidase inhibition for improvement of long-term outcomes following ischaemic stroke and transient ischaemic attack (XILO-FIST) trial is designed to test whether allopurinol reduces the rate of WMH progression and BP in people with recent ischaemic stroke. The gene discussed is XDH; the disease is transient ischemic attack.